IgD monoclonal gammopathy with long‐term follow‐up
- 1 October 1994
- journal article
- case report
- Published by Wiley in British Journal of Haematology
- Vol. 88 (2) , 395-396
- https://doi.org/10.1111/j.1365-2141.1994.tb05037.x
Abstract
Summary. The presence of a serum IgD monoclonal protein (M‐protein) is usually indicative of a malignant plasma cell disorder. However, one case of well‐documented benign monoclonal gammopathy (BMG) of IgD type has been reported. We describe another patient with IgD monoclonal gammopathy of undetermined significance (MGUS) with long‐term follow‐up. In this patients an IgD λ M‐protein was found on routine serum electrophoresis. She is alive and has no evidence of multiple myeloma or amyloidosis after 8 years of follow‐up. Although IgD MGUS is exceedingly rare, this case demonstrates that the presence of a serum IgD M‐protein is not necessarily synonymous with a malignant plasma cell process.Keywords
This publication has 10 references indexed in Scilit:
- “Benign” Monoclonal Gammopathy—After 20 to 35 Years of Follow-UpMayo Clinic Proceedings, 1993
- Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significanceBritish Journal of Haematology, 1992
- Immunoglobulin D benign monoclonal gammopathy. A case reportCancer, 1991
- IgD-λ monoclonal gammaopathy and axonal neuropathyJournal of Internal Medicine, 1989
- 'Benign' Monoclonal GammopathyPublished by American Medical Association (AMA) ,1984
- Idiopathic Bence Jones ProteinuriaNew England Journal of Medicine, 1982
- Monoclonal gammopathy of undetermined significanceThe American Journal of Medicine, 1978
- Immunochemical Classes of Myelomatosis. INCLUDING DATA FROM A THERAPEUTIC TRIAL CONDUCTED BY A MEDICAL RESEARCH COUNCIL WORKING PARTY*British Journal of Haematology, 1969
- Younger Age of Presentation and Extraosseous Tumour in IgD MyelomatosisBMJ, 1969